RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Effective Postoperative Use of Dexmedetomidine in a Child with Severe Pulmonary Arterial Hypertension Secondary to Congenital Ventricular Septal Defect

      한글로보기

      https://www.riss.kr/link?id=A103921024

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Although α2-adrenoceptor agonists are widely used as postoperative sedatives in adults, the postoperative effects in pediatric patientswith secondary pulmonary arterial hypertension (PAH) due to congenital heart disease are not well known. We experie...

      Although α2-adrenoceptor agonists are widely used as postoperative sedatives in adults, the postoperative effects in pediatric patientswith secondary pulmonary arterial hypertension (PAH) due to congenital heart disease are not well known. We experienced a case of successful ventilator weaning with continuous intravenous administration of dexmedetomidine (DEX) after surgical correction in a 46-month-old child with congenital ventricular septal defect (VSD) with severe PAH. She underwent VSD closure on cardiopulmonarybypass (CPB). After successful weaning from the CPB, hemodynamics and oxygenation were stabilized on DEX and nitroglycerin in the intensive care unit. The patient was successfully weaned from the ventilator 46 hours after surgery. The transthoracic echocardiogramtwo weeks after surgery showed a closed VSD with no residual shunt and trivial tricuspid regurgitation (Vmax = 2.5 m/sec) without PAH.

      더보기

      참고문헌 (Reference)

      1 Buck ML, "Use of dexmedetomidine in the pediatric intensive care unit" 28 : 51-57, 2008

      2 Mukhtar AM, "The use of dexmedetomidine in pediatric cardiac surgery" 103 : 52-56, 2006

      3 Hall JE, "Sedative, amnestic, and analgesic properties of smalldose dexmedetomidine infusions" 90 : 699-705, 2000

      4 Bejian S, "Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit" 19 : 98-104, 2009

      5 Carmosino MJ, "Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization" 104 : 521-527, 2007

      6 Bloor BC, "Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes" 77 : 1134-1142, 1992

      7 Belleville JP, "Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate" 77 : 1125-1133, 1992

      8 Shehabi Y, "Dexmedetomidine infusion for more than 24hours in critically ill patients: sedative and cardiovascular effects" 30 : 2188-2196, 2004

      9 Nemoto S, "Dexmedetomidine enables not only optimal sedation but also minimizing life-threatening morbidities in intensive care management after pediatric cardiovascular surgery" 39 : 238-, 2011

      10 Isik B, "Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery" 16 : 748-753, 2006

      1 Buck ML, "Use of dexmedetomidine in the pediatric intensive care unit" 28 : 51-57, 2008

      2 Mukhtar AM, "The use of dexmedetomidine in pediatric cardiac surgery" 103 : 52-56, 2006

      3 Hall JE, "Sedative, amnestic, and analgesic properties of smalldose dexmedetomidine infusions" 90 : 699-705, 2000

      4 Bejian S, "Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit" 19 : 98-104, 2009

      5 Carmosino MJ, "Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization" 104 : 521-527, 2007

      6 Bloor BC, "Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes" 77 : 1134-1142, 1992

      7 Belleville JP, "Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate" 77 : 1125-1133, 1992

      8 Shehabi Y, "Dexmedetomidine infusion for more than 24hours in critically ill patients: sedative and cardiovascular effects" 30 : 2188-2196, 2004

      9 Nemoto S, "Dexmedetomidine enables not only optimal sedation but also minimizing life-threatening morbidities in intensive care management after pediatric cardiovascular surgery" 39 : 238-, 2011

      10 Isik B, "Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery" 16 : 748-753, 2006

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2025 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2021-12-01 평가 등재후보로 하락 (재인증) KCI등재후보
      2018-02-28 학술지명변경 한글명 : The Korean Journal of Critical Care Medicine -> Acute and Critical Care
      외국어명 : The Korean Journal of Critical Care Medicine -> Acute and Critical Care
      KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2016-06-24 학술지명변경 한글명 : 대한중환자의학회지 -> The Korean Journal of Critical Care Medicine
      외국어명 : The Korean Society of Critical Care Medicine -> The Korean Journal of Critical Care Medicine
      KCI등재
      2015-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2013-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2011-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2009-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.07 0.07 0.09
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.1 0.08 0.289 0.12
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼